Condition: Early Gastric Cancer · Endoscopic Submucosal Dissection · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
This study is a single-center, prospective, group-controlled clinical trial, aiming to clarify the relationship between the depth of dissection and scar formation in the treatment of early gastric cancer by ESD, and to provide high-quality evidence-based medicine for the treatment of early gastric cancer.
This description comes directly from the study's public registry record.
Yuqi Wang, Doctor · +86-15267019821 · wyq@zju.edu.cn
Always discuss trial participation with your own doctor first.
| Second affiliated hospital, school of medicine, Zhejiang University | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05323929